Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Interventional Spine gets EU nod to double market opportunity:

This article was originally published in Clinica

Executive Summary

In what more than doubles the market potential for its Percudyn dynamic stabilisation device outside the US, Interventional Spine has received European approval to expand the indications for the device. In addition to its original 2006 clearance for degenerative disc disease, the percutaneous product can be used to treat a number of conditions including neurogenic intermittent claudication due to lumbar spinal stenosis, spondylolisthesis and Baastrup's syndrome. The Percudyn system is to be launched at this months Spine Arthroplasty Society meeting in Berlin, Germany, said the the Irvine, California firm.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT048250

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel